Brief: Seelos Therapeutics Announces Close Of Enrollment Of Its Registration Directed Study Of SLS-002
22/06/2023 13:30
June 22 (Reuters) - Seelos Therapeutics Inc SEEL.O :
* SEELOS THERAPEUTICS - ANNOUNCED CLOSE OF ENROLLMENT OF ITS
REGISTRATION DIRECTED STUDY OF SLS-002
* SEELOS THERAPEUTICS - TOP-LINE DATA FROM REGISTRATION
DIRECTED
STUDY OF SLS-002 EXPECTED IN Q3 OF 2023
Source text for Eikon: ID:nPn3rcPh1a
Further company coverage: SEEL.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Seelos Therapeutics
See all newsBrief: Seelos Therapeutics Commences Chapter 11 Proceedings- Court Filing
Brief: Seelos Therapeutics Announces Notice Of Delisting From Nasdaq And Transfer Of Listing To Over-The-Counter Market
Brief: Seelos Announces Postponement Of Its Annual Meeting Of Stockholders
Brief: Seelos Therapeutics Announces 1-For-16 Reverse Stock Split
U.S. STOCKS ON THE MOVE-Copper miners, Visa, Bluebird bio